Prolonged treatment with glycerophosphocholine, an acetylcholine precursor, does not disclosure the potentiating effect of cholinesterase inhibitors on GHRH-induced somatotroph secretion in anorexia nervosa

Journal of Endocrinological Investigation

Volumn 26, Issue 6, 2003, Pages 503-507

  Fassino, Secondo ^a   Lanfranco, F ^b   Abbate Daga, G ^a   Mondelli, V ^a   Destefanis, S ^b   Rovera, G G ^a   Camanni, F ^b   Ghigo, E ^b   Arvat, E ^b   Gianotti, L ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

Author keywords

Acetylcholine; Anorexia nervosa; GHRH; Glycerophosphocholine; Growth hormone; Pyridostigmine

Indexed keywords

ACETYLCHOLINE DERIVATIVE; BREZAL; CHOLINESTERASE INHIBITOR; GLYCEROPHOSPHORYLCHOLINE; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; PYRIDOSTIGMINE;

ABDOMINAL PAIN; ADULT; ANOREXIA NERVOSA; ARTICLE; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; DRUG WITHDRAWAL; FEMALE; FLUSHING; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE RELEASE; HORMONE RESPONSE; HUMAN; LONG TERM CARE; SIDE EFFECT;

EID: 0042024954     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03345211     Document Type: Article

References (37)

1. Dieguez C., Page M.D., Scanlon M.F. Growth hormone neuroregulation and its alterations in disease states. Clin. Endocrinol. (Oxf.) 1989, 28: 109-121.
2. Stoving R.K., Hangaard J., Hansen-Nord M., Hagen C. A review of endocrine changes in anorexia nervosa. Biol. Psych. 1999, 33: 139-152.
3. Gianotti L., Lanfranco F., Ramunni J., Destefanis S., Ghigo E., Arvat E. GH/IGF-I axis in anorexia nervosa. Eat. Weight Disord. 2000, 7: 94-10.
4. Ross R.J.M., Chew S.L. Acquired growth hormone resistance. Eur. J. Endocrinol. 1995, 132: 655-660.
5. Gianotti L., Pincelli A.I., Scacchi M., et al. Effects of recombinant human insulin-like growth factor I administration on spontaneous and growth hormone-releasing hormone-stimulated GH secretion in anorexia nervosa. J. Clin. Endocrinol. Metab. 2000, 85: 2805-2809.
6. Frankel R.J., Jenkins J.S. Hypothalamic pituitary function in anorexia nervosa. Acta Endocrinol. (Copenh.) 1975, 78: 209-221.
7. Sherman B.M., Halmi K.A. Effect of nutritional rehabilitation on hypothalamic-pituitary function in anorexia. In: Vigersky R.A. (Ed.), Anorexia Nervosa. Raven Press, New York, 1977, pp. 211-223.
8. De Marinis L., Folli G., D'Amico C., et al. Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa. J. Clin. Endocrinol. Metab. 1988, 66: 598-602.
9. Brambilla F., Ferrari E., Cavagnini F., et al. Alpha 2-adrenoceptor sensitivity in anorexia nervosa: Growth hormone response to clonidine or growth hormone-releasing hormone stimulation. Biol. Psych. 1989, 25: 256-264.
10. Tamai H.T., Komaki G., Matsubayashi S., et al. Effect of cholinergic muscarinic receptor blockade on human growth hormone (GH)-releasing hormone-(1-44)-induced-GH secretion in anorexia nervosa. J. Clin. Endocrinol. Metab. 1990, 70: 738-741.
11. Rolla M., Andreoni A., Belliti D., Cristofani R., Ferdeghini M., Müller E.E. Blockade of cholinergic muscarinic receptors by pirenzepine and GHRH-induced GH secretion in the acute and recovery phase of anorexia nervosa and atypical eating disorder. Biol. Psych. 1991, 29: 1079-1091.
12. Ghigo E., Arvat E., Gianotti L., et al. Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa. Biol. Psych. 1994, 36: 689-695.
13. Müller E.E., Rolla M., Ghigo E., et al. Involvement of brain cathecolamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological states. Pathophysiological, diagnostic and therapeutic implications. Drugs 1995, 50: 805-837.
14. Gianotti L., Arvat E., Valetto M.R., et al. Effects of β-adrenergic agonists and antagonists on the GH response to GHRH in anorexia nervosa. Biol. Psych. 1998, 43: 181-187.
15. Massara F., Ghigo E., Goffi S., Molinatti G.M., Müller E.E., Camanni F. Blockade of hp GRF40-induced GH release in normal man by a cholinergic muscarinic antagonist. J. Clin. Endocrinol. Metab. 1984; 59: 1025-1029
16. Richardson S.B., Hollander G.S., D'Eletto R.D., Greenleaf P.H., Thau C. Acetylcholine inhibits the release of somatostatin from rat hypothalamus in vitro. Endocrinology 1980, 107: 122-129.
17. Casanueva F.F., Villanueva L., Dieguez C., et al. Atropine blockade of growth hormone (GH)-releasing hormone-induced GH secretion in man is not exerted at pituitary level. J. Clin. Endocrinol. Metab. 1986, 62: 186-191.
18. Locatelli V., Torsello A., Redaelli M., Ghigo E., Massara F., Müller E.E. Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: Evidence for mediation by somatostatin. J. Endocrinol. 1986, 111: 271-278.
19. Massara F., Ghigo E., Molinatti P., et al. Potentiation of cholinergic tone by pyridostigmine bromide reinstates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in man. Acta Endocrinol. (Copenh.) 1986, 113: 12-16.
20. Ross R.J., Tsagaraskis S., Grossman A., et al. Growth hormone feed-back occurs through modulation of hypothalamic somatostatin under cholinergic control: Studies with pyridostigmine and growth hormone-releasing hormone. Clin. Endocrinol. (Oxf.) 1987, 27: 727-733.
21. Torsello A., Panzeri G., Cermenati P., et al. Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone feed-back regulation in the rat. J. Endocrinol. 1988, 117: 273-278.
22. Alba-Roth J., Müller A.O., Schopol J., Von Wender K. Arginine stimulates growth hormone secretion by suppressing endogenous somatostatin secretion. J. Clin. Endocrinol. Metab. 1988, 67: 1186-1190.
23. Amenta F., Parnetti L., Gallai V., Wallin A. Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatment or inappropriate approaches? Mech. Ageing Dev. 2001, 122: 2025-2040.
24. Locatelli V., Torsello A., Redaelli M., Ghigo E., Massara F., Muller E.E. Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: Evidence for mediation of somatostatin. J. Endocrinol. 1986, 11: 271-274.
25. Casanueva F.F., Villanueva L., Cordido F., et al. Dissociation in the capability to elicit growth hormone discharge between direct and indirect cholinergic agonist drugs, and lack of effect of both compounds on cortisol secretion. J. Neuroendocrinol. 1989, 1: 379-381.
26. Mazza E., Ghigo E., Boffano G., et al. Effects of direct and indirect acetylcholine receptor agonists on growth hormone secretion in humans. Eur. J. Pharmacol. 1994; 254: 17-20.
27. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 1985, 30: 408-414.
28. American Psychiatry Association. Diagnostic and Statistical Manual of Mental Disorders. Fourth Edition, Text Revision 2000, Washington, D.C.
29. Gerner R.H., cohen D.J., Fairbanks L., et al. CSF neurochemistry of women with anorexia nervosa and normal women. Am. J. Psychiatry 1984, 141: 1441-1444.
30. Schlemmer H.P., Mockel R., Marcus A., et al. Proton magnetic resonance spectroscopy in acute, juvenile anorexia nervosa. Psychiatry Res. 1998, 82: 171-179.
31. Blackard W.G., Waddel C.C. Cholinergic blockade and growth hormone responsiveness to insulin hypoglicaemia. Proc. Soc. Exp. Biol. Med. 1969, 1: 131-137.
32. Cordido F., Dieguez C., Casanueva F.F. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the GH secretion elicited by clonidine, arginine or hypoglicaemia in normal and obese subjects. J. Clin. Endocrinol. Metab. 1990, 70: 1361-1365.
33. Coiro V., Passeri M., Gardini E., et al. Reduced sensitivity to pirenzepine-induced blockade of growth hormone response to arginine, exercise and growth hormone-releasing hormone in type I diabetic subjects. Metabolism 1990, 39: 668-675.
34. Delvenne V., Lotstra F., Goldman S., et al. Brain hypometabolism of glucose in anorexia nervosa: A PET scan study. Biol. Psych. 1995, 37: 161-169.
35. Delvenne V., Goldman S., De Maertelaer V., Simon Y., Luxen A., Lotstra F. Brain hypometabolism of glucose in anorexia nervosa: Normalization after weight gain. Biol. Psych. 1996, 40: 761-768.
36. Delvenne V., Goldman S., De Maertelaer V., Lotstra F. Brain glucose metabolism in eating disorders assessed by positron emission tomography. Int. J. Eat. Disord. 1999, 25: 29-37.
37. Gibbs R.B. Effects of gonadal hormone replacement on measures of basal forebrain cholinergic function. Neuroscience 2000, 101: 931-938.